Neuraxis, Inc.
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -589.8% | -494.8% | -206.0% | -264.1% | -208.9% | -231.0% | -179.0% | -164.1% | -175.9% | -199.8% | -76.5% | -53.4% | -105.7% | |
| 2.1% | 2.0% | 1.7% | 1.8% | 1.4% | 0.9% | 0.7% | 1.4% | 2.0% | 2.5% | 1.0% | 0.9% | 1.4% | |
| 534.1% | -338.7% | 42.8% | 127.8% | 40.8% | 9.7% | 11.8% | 19.4% | 19.8% | 16.2% | 20.5% | 33.2% | 24.2% | |
| -530.5% | 146.6% | 65.5% | 63.6% | -39.8% | -53.2% | 61.5% | 1.1% | 59.9% | -45.1% | 5.9% | 16.2% | 8.6% | |
| 0.6% | 3.0% | 2.3% | 1.4% | 0.7% | 0.0% | 2.0% | 0.8% | 0.0% | 0.6% | 0.0% | 0.3% | 0.2% | |
| -8.9% | – | -2.3% | -1.4% | -0.7% | – | -2.0% | -0.8% | – | -10.9% | – | -0.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | 0.0% | – | |
| – | – | – | – | -16.1% | 17.7% | -7.8% | -9.5% | -8.7% | -5.8% | -3.6% | -3.0% | -4.6% | |
| 747.4% | 369.3% | 208.8% | 540.9% | -16.1% | 682.4% | -7.8% | 610.4% | -22.7% | 271.5% | 207.9% | 118.2% | 151.7% | |
| 148.7% | -128.5% | 0.5% | 275.3% | -225.7% | 451.4% | -188.9% | 445.5% | -198.6% | 60.7% | 131.5% | 64.5% | 43.9% | |
| -590.4% | -497.8% | -208.3% | -265.5% | -209.6% | -231.0% | -181.1% | -164.9% | -175.9% | -200.4% | -76.5% | -53.7% | -106.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.